Financhill
Sell
37

LOW Quote, Financials, Valuation and Earnings

Last price:
$222.97
Seasonality move :
3.4%
Day range:
$223.40 - $226.63
52-week range:
$211.80 - $287.01
Dividend yield:
2.02%
P/E ratio:
18.50x
P/S ratio:
1.53x
P/B ratio:
--
Volume:
2.8M
Avg. volume:
2.7M
1-year change:
-7.71%
Market cap:
$126.5B
Revenue:
$83.7B
EPS (TTM):
$12.21

Analysts' Opinion

  • Consensus Rating
    Lowe's Companies has received a consensus rating of Buy. The company's average rating is a Buy based on 17 Buy ratings, 14 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $279.81, Lowe's Companies has an estimated upside of 23.89% from its current price of $225.85.
  • Price Target Downside
    According to analysts, the lowest downside price target is $217.00 representing 100% downside risk from its current price of $225.85.

Fair Value

  • According to the consensus of 32 analysts, Lowe's Companies has 23.89% upside to fair value with a price target of $279.81 per share.

LOW vs. S&P 500

  • Over the past 5 trading days, Lowe's Companies has underperformed the S&P 500 by -8.07% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Lowe's Companies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Lowe's Companies revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Lowe's Companies reported revenues of $18.6B.

Earnings Growth

  • Lowe's Companies has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Lowe's Companies reported earnings per share of $1.99.
Enterprise value:
159.8B
EV / Invested capital:
7.52x
Price / LTM sales:
1.53x
EV / EBIT:
15.09x
EV / Revenue:
1.91x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
20.76x
Price / Operating cash flow:
16.66x
Enterprise value / EBITDA:
12.72x
Gross Profit (TTM):
$27.9B
Return On Assets:
15.82%
Net Income Margin (TTM):
8.32%
Return On Equity:
--
Return On Invested Capital:
32.31%
Operating Margin:
9.86%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-31 2024-01-31 2025-01-31 2024-01-31 2025-01-31
Income Statement
Revenue $97.1B $86.4B $83.7B $18.6B $18.6B
Gross Profit $32.3B $28.8B $27.9B $6B $6.1B
Operating Income $10.2B $11.6B $10.5B $1.7B $1.8B
EBITDA $12.2B $13.6B $12.6B $2.2B $2.3B
Diluted EPS $10.01 $13.16 $12.21 $1.77 $1.99
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Balance Sheet
Current Assets $22.3B $20.1B $21.4B $19.1B $20.4B
Total Assets $46.7B $44.6B $43.7B $41.8B $43.1B
Current Liabilities $18.7B $19.7B $19.5B $15.6B $18.8B
Total Liabilities $45.3B $49.5B $58B $56.8B $57.3B
Total Equity $1.4B -$4.8B -$14.3B -$15.1B -$14.2B
Total Debt $21.8B $24.7B $34B $35.9B $35.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-31 2024-01-31 2025-01-31 2024-01-31 2025-01-31
Cash Flow Statement
Cash Flow Operations $8.6B $8.1B $9.6B $1.1B $911M
Cash From Investing -$1.3B -$1.9B -$1.7B -$595M -$418M
Cash From Financing -$7B -$6.7B -$7B -$802M -$2B
Free Cash Flow $6.8B $6.2B $7.7B $488M $363M
LOW
Sector
Market Cap
$126.5B
$413.9M
Price % of 52-Week High
78.69%
70.13%
Dividend Yield
2.02%
0%
Shareholder Yield
4.59%
3.83%
1-Year Price Total Return
-7.72%
-14.97%
Beta (5-Year)
1.122
0.943
Dividend yield:
2.02%
Annualized payout:
$4.55
Payout ratio:
36.88%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $232.88
200-day SMA
Sell
Level $249.09
Bollinger Bands (100)
Sell
Level 245.2 - 270.62
Chaikin Money Flow
Sell
Level -94.7M
20-day SMA
Sell
Level $241.01
Relative Strength Index (RSI14)
Sell
Level 31.40
ADX Line
Sell
Level 26.77
Williams %R
Buy
Level -82.6648
50-day SMA
Sell
Level $249.72
MACD (12, 26)
Sell
Level -7.18
25-day Aroon Oscillator
Sell
Level -84
On Balance Volume
Neutral
Level 632.1M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8305)
Sell
CA Score (Annual)
Level (-2.4578)
Buy
Beneish M-Score (Annual)
Level (-3.808)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (3.4704)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Lowe's is the second-largest home improvement retailer in the world, operating more than 1,700 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe’s Canada, Réno-Dépôt, and Dick’s Lumber). The firm’s stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's primarily targets retail do-it-yourself (around 70% of sales) and do-it-for-me customers, but has expanded its commercial and professional business clients to 30% from less than 20% in the past six years. We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management’s market size estimates.

Stock Forecast FAQ

In the current month, LOW has received 17 Buy ratings 14 Hold ratings, and 1 Sell ratings. The LOW average analyst price target in the past 3 months is $279.81.

  • Where Will Lowe's Companies Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Lowe's Companies share price will rise to $279.81 per share over the next 12 months.

  • What Do Analysts Say About Lowe's Companies?

    Analysts are divided on their view about Lowe's Companies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lowe's Companies is a Sell and believe this share price will drop from its current level to $217.00.

  • What Is Lowe's Companies's Price Target?

    The price target for Lowe's Companies over the next 1-year time period is forecast to be $279.81 according to 32 Wall Street analysts, 17 of them rate the stock a Buy, 1 rates the stock a Sell, and 14 analysts rate the stock a Hold.

  • Is LOW A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Lowe's Companies is a Buy. 17 of 32 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of LOW?

    You can purchase shares of Lowe's Companies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lowe's Companies shares.

  • What Is The Lowe's Companies Share Price Today?

    Lowe's Companies was last trading at $222.97 per share. This represents the most recent stock quote for Lowe's Companies. Yesterday, Lowe's Companies closed at $225.85 per share.

  • How To Buy Lowe's Companies Stock Online?

    In order to purchase Lowe's Companies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock